kombiglyza xr 5/1000 mg 30 tablets
كومبيجليز اكس ار 2.5 / 1000 مجم 60 قرص
saxagliptin+metforminThe published official price. Pharmacies may differ slightly.
- Strength
- 5/1000mg
- Form
- tablet
- Manufacturer
- bristol-myers squibb > united pharma international-egypt
- Route
- oral.solid
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
A combination of saxagliptin (DPP-4 inhibitor) and metformin (biguanide) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not use if
Contraindicated in patients with severe renal impairment (eGFR below 30 mL/min/1.73 m²), acute or chronic metabolic acidosis including diabetic ketoacidosis, and history of serious hypersensitivity to saxagliptin or metformin.
Side effects
Common adverse reactions include upper respiratory tract infection, urinary tract infection, and nasopharyngitis. Serious risks include lactic acidosis (metformin), pancreatitis (saxagliptin), heart failure hospitalization, and hypoglycemia when combined with insulin secretagogues. Vitamin B12 deficiency may occur with long-term metformin use.
Warnings
Boxed warning: metformin-associated lactic acidosis can be fatal; risk increases with renal impairment, hepatic impairment, congestive heart failure, and excessive alcohol intake. Hold metformin before iodinated contrast procedures. Monitor renal function regularly. Saxagliptin has been associated with an increased risk of heart failure hospitalization.
How it works
Saxagliptin inhibits the enzyme DPP-4, thereby increasing active incretin hormone (GLP-1 and GIP) concentrations, which stimulate glucose-dependent insulin release and suppress glucagon. Metformin decreases hepatic glucose production, reduces intestinal glucose absorption, and improves peripheral insulin sensitivity.
Storage
Store at room temperature, 20°C to 25°C. Protect from moisture.